ArticleCirculation research2017
Epigenomic Disruption of Cardiovascular Care: What It Will Take.
Emma Monte, Matthew A Fischer, Thomas M Vondriska
Abstract readEditorialComment
In one paragraphArticle in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Emma MonteFrom the Department of Genetics, Stanford University, CA (E.M.); and Department of Anesthesiology and Perioperative Medicine (M.A.F., T.M.V.), Department of Medicine/Cardiology (T.M.V.), and Department of Physiology (T.M.V.), David Geffen School of Medicine, University of California, Los Angeles.
Matthew A FischerFrom the Department of Genetics, Stanford University, CA (E.M.); and Department of Anesthesiology and Perioperative Medicine (M.A.F., T.M.V.), Department of Medicine/Cardiology (T.M.V.), and Department of Physiology (T.M.V.), David Geffen School of Medicine, University of California, Los Angeles.
Thomas M VondriskaFrom the Department of Genetics, Stanford University, CA (E.M.); and Department of Anesthesiology and Perioperative Medicine (M.A.F., T.M.V.), Department of Medicine/Cardiology (T.M.V.), and Department of Physiology (T.M.V.), David Geffen School of Medicine, University of California, Los Angeles. tvondriska@mednet.ucla.edu.
Funding
INSTITUTIONAL TRAINING GRANT IN GENOME SCIENCET32HG000044 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL P. SNYDER · 1995 to 2026
$32.2MDynamics of Cardiac Nuclei in Heart DiseaseR01HL105699 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2011 to 2025
$5.0MEpigenomic Mechanisms of Heart FailureR01HL129639 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2015 to 2018
$2.6MSystems Analysis of Cardiac Chromatin StructureR01HL115238 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2012 to 2016
$1.9MNHGRI NIH HHS T32 HG000044NHLBI NIH HHS R01 HL105699NHLBI NIH HHS R01 HL115238NHLBI NIH HHS R01 HL129639
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Acute Coronary SyndromeEpigenomicsDNA MethylationGenomicsHumansacute coronary syndromeatrial fibrillationEditorialsepigenomicsgenomics
Identifiers
PMID28546346
PMCPMC5527682
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390